‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That
A groundbreaking initiative aims to revolutionize the treatment of rare diseases by focusing on gene therapy, which has typically been sidelined by pharmaceutical companies. This nonprofit hopes to make gene therapy more accessible and standardized, turning it into a routine medical procedure rather than a custom-made drug. The effort is crucial as it addresses the often neglected needs of patients with rare conditions, potentially offering new hope and better quality of life. This movement could shift the landscape of medical innovation, emphasizing inclusivity and accessibility in healthcare advancements.
Original Source
Read the full article at Nytimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.